Corner Growth Acquisition Corp.

2024 Q2 Form 10-Q Financial Statement

#000141057824001466 Filed on August 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q2

Balance Sheet

Concept 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $21.38K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $61.47K
Receivables
Other Receivables
Total Short-Term Assets $82.85K
YoY Change -42.21%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $3.737M
YoY Change -15.75%
TOTAL ASSETS
Total Short-Term Assets $82.85K
Total Long-Term Assets $3.737M
Total Assets $3.820M
YoY Change -16.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $3.783M
YoY Change 118.92%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.591M
YoY Change 106.73%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $6.591M
Total Long-Term Liabilities
Total Liabilities $17.78M
YoY Change 79.42%
SHAREHOLDERS EQUITY
Retained Earnings -$17.27M
YoY Change 76.81%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$17.27M
YoY Change
Total Liabilities & Shareholders Equity $3.820M
YoY Change -16.58%

Cashflow Statement

Concept 2024 Q2

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Other Liability Current Related Party Type Extensible Enumeration
OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#RelatedPartyMember
CY2023Q4 us-gaap Other Liability Current Related Party Type Extensible Enumeration
OtherLiabilityCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#RelatedPartyMember
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
dei Entity Central Index Key
EntityCentralIndexKey
0001829953
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
CORNER GROWTH ACQUISITION CORP.
dei Entity File Number
EntityFileNumber
001-39814
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1563902
dei Entity Address Address Line1
EntityAddressAddressLine1
251 Lytton Avenue
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 200
dei Entity Address City Or Town
EntityAddressCityOrTown
Palo Alto
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94301
dei City Area Code
CityAreaCode
650
dei Local Phone Number
LocalPhoneNumber
543-8180
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2024Q2 us-gaap Cash
Cash
21375
CY2023Q4 us-gaap Cash
Cash
21631
CY2024Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
61471
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
77969
CY2024Q2 us-gaap Assets Current
AssetsCurrent
82846
CY2023Q4 us-gaap Assets Current
AssetsCurrent
99600
CY2024Q2 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
3737286
CY2023Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
4553517
CY2024Q2 us-gaap Assets
Assets
3820132
CY2023Q4 us-gaap Assets
Assets
4653117
CY2024Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2379514
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1910848
CY2024Q2 coolu Due To Shareholders
DueToShareholders
428962
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3782631
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2473365
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
6591107
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4384213
CY2024Q2 coolu Warrant Liability Noncurrent
WarrantLiabilityNoncurrent
4188760
CY2023Q4 coolu Warrant Liability Noncurrent
WarrantLiabilityNoncurrent
1297866
CY2024Q2 coolu Deferred Underwriting Fee Payable Noncurrent
DeferredUnderwritingFeePayableNoncurrent
7000000
CY2023Q4 coolu Deferred Underwriting Fee Payable Noncurrent
DeferredUnderwritingFeePayableNoncurrent
7000000
CY2024Q2 us-gaap Liabilities
Liabilities
17779867
CY2023Q4 us-gaap Liabilities
Liabilities
12682079
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17269059
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12583479
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-17268059
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-12582479
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3820132
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4653117
CY2024Q2 coolu Operating And Formation Costs
OperatingAndFormationCosts
1088768
coolu Operating And Formation Costs
OperatingAndFormationCosts
1794686
CY2023Q2 coolu Operating And Formation Costs
OperatingAndFormationCosts
1238047
coolu Operating And Formation Costs
OperatingAndFormationCosts
1890082
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1088768
us-gaap Operating Income Loss
OperatingIncomeLoss
-1794686
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1238047
us-gaap Operating Income Loss
OperatingIncomeLoss
-1890082
CY2024Q2 us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
39495
us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
95277
CY2023Q2 us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
139599
us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
294382
CY2023Q2 coolu Transaction Costs
TransactionCosts
102000
coolu Transaction Costs
TransactionCosts
102000
CY2024Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1027827
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2890894
CY2023Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
209333
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2093333
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-2077100
us-gaap Net Income Loss
NetIncomeLoss
-4590303
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1409781
us-gaap Net Income Loss
NetIncomeLoss
-3791033
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-12582479
CY2024Q1 coolu Initial Measurement Of Common Stock Subject To Redemption Against Additional Paid In Capital Value
InitialMeasurementOfCommonStockSubjectToRedemptionAgainstAdditionalPaidInCapitalValue
55782
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-2513203
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-15151464
CY2024Q2 coolu Initial Measurement Of Common Stock Subject To Redemption Against Additional Paid In Capital Value
InitialMeasurementOfCommonStockSubjectToRedemptionAgainstAdditionalPaidInCapitalValue
39495
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-2077100
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-17268059
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-5782772
CY2023Q1 coolu Initial Measurement Of Common Stock Subject To Redemption Against Additional Paid In Capital Value
InitialMeasurementOfCommonStockSubjectToRedemptionAgainstAdditionalPaidInCapitalValue
154783
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-2381252
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-8318807
CY2023Q2 coolu Remeasurement Of Deferred Underwriting Fee Payable
RemeasurementOfDeferredUnderwritingFeePayable
-3000000
CY2023Q2 coolu Transaction Cost Allocation For Change In Deferred Underwriting Fee
TransactionCostAllocationForChangeInDeferredUnderwritingFee
102000
CY2023Q2 coolu Initial Measurement Of Common Stock Subject To Redemption Against Additional Paid In Capital Value
InitialMeasurementOfCommonStockSubjectToRedemptionAgainstAdditionalPaidInCapitalValue
139599
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1409781
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-12766187
us-gaap Net Income Loss
NetIncomeLoss
-4590303
us-gaap Net Income Loss
NetIncomeLoss
-3791033
us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
95277
us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
294382
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2890894
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2093333
coolu Transaction Costs Attributable To Warrant Liabilities
TransactionCostsAttributableToWarrantLiabilities
102000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1309266
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
795275
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
468666
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
937876
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-16498
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-152516
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-256
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4415
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
911508
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
11347734
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
911508
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
11347734
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
911508
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
11347734
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-911508
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-11347734
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-256
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-4415
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21631
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31547
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21375
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
27132
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
95277
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
294382
coolu Accrual Of Deferred Underwriting Fee Payable
AccrualOfDeferredUnderwritingFeePayable
3000000
coolu Non Cash Activity Of Due To Shareholders
NonCashActivityOfDueToShareholders
428962
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
982
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2020-10-20
CY2023Q2 coolu Forfeiture Of Deferred Underwriting Fee Payable
ForfeitureOfDeferredUnderwritingFeePayable
7000000
CY2020Q4 coolu Deferred Underwriting Fee Payable Noncurrent
DeferredUnderwritingFeePayableNoncurrent
14000000
CY2023Q2 coolu Deferred Underwriting Fee Payable Noncurrent
DeferredUnderwritingFeePayableNoncurrent
7000000
CY2024Q2 us-gaap Share Price
SharePrice
10.00
CY2024Q2 coolu Percentage Of Redeeming Shares Of Public Shares Without The Companys Prior Written Consent
PercentageOfRedeemingSharesOfPublicSharesWithoutTheCompanysPriorWrittenConsent
0.15
CY2022Q4 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
393676799
CY2023Q1 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
3262655
coolu Lock In Period Of Alignment Shares To Forfeited Following Closing Of Business Combination
LockInPeriodOfAlignmentSharesToForfeitedFollowingClosingOfBusinessCombination
P180D
coolu Dissolution Expense
DissolutionExpense
100000
CY2024Q2 coolu Per Share Amount Available For Distribution
PerShareAmountAvailableForDistribution
10.00
CY2024Q2 us-gaap Cash
Cash
21375
CY2024Q2 us-gaap Assets Held In Trust
AssetsHeldInTrust
3737286
CY2024Q2 coolu Working Capital Deficit
WorkingCapitalDeficit
6508261
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:22.3pt;margin:0pt 0pt 12pt 0pt;">The preparation of condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Concentration of Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:22.3pt;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage of $250,000. At June 30, 2024, the Company has not experienced losses on these accounts.</p>
CY2024Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2023Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2023Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2024Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2024Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2024Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
297942
CY2023Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
419938
CY2023Q2 us-gaap Assets
Assets
0
CY2020Q4 coolu Minimum Lock In Period For Transfer Assign Or Sell Warrants After Completion Of Ipo
MinimumLockInPeriodForTransferAssignOrSellWarrantsAfterCompletionOfIpo
P30D
CY2024Q2 coolu Deferred Underwriting Fee Per Unit
DeferredUnderwritingFeePerUnit
0.35
CY2023Q2 coolu Forfeiture Of Deferred Underwriting Fee Payable
ForfeitureOfDeferredUnderwritingFeePayable
7000000
CY2020Q4 coolu Deferred Underwriting Fee Payable Noncurrent
DeferredUnderwritingFeePayableNoncurrent
14000000
CY2024Q2 coolu Deferred Underwriting Fee Payable Noncurrent
DeferredUnderwritingFeePayableNoncurrent
7000000
CY2024Q2 coolu Percentage Of Non Refundable Fee Payable To Underwriter
PercentageOfNonRefundableFeePayableToUnderwriter
0.030
CY2023Q2 coolu Cash Payments If The Business Combination Not Consummated
CashPaymentsIfTheBusinessCombinationNotConsummated
2000000
CY2024Q2 coolu Percentage Of Capital Raised For Business Combination To Total Equity Proceeds
PercentageOfCapitalRaisedForBusinessCombinationToTotalEquityProceeds
0.60
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q2 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
370088
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001410578-24-001466-index-headers.html Edgar Link pending
0001410578-24-001466-index.html Edgar Link pending
0001410578-24-001466.txt Edgar Link pending
0001410578-24-001466-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tmb-20240630.xsd Edgar Link pending
tmb-20240630x10q.htm Edgar Link pending
tmb-20240630xex31d1.htm Edgar Link pending
tmb-20240630xex31d2.htm Edgar Link pending
tmb-20240630xex32d1.htm Edgar Link pending
tmb-20240630xex32d2.htm Edgar Link pending
tmb-20240630_cal.xml Edgar Link unprocessable
tmb-20240630_def.xml Edgar Link unprocessable
tmb-20240630_lab.xml Edgar Link unprocessable
tmb-20240630x10q_htm.xml Edgar Link completed
tmb-20240630_pre.xml Edgar Link unprocessable